14May
12May
The Pros from Dover
Boston Harbor Angel members, Ziad Moukheiber and David Powsner, are the hosts of Failure – the Podcast, a podcast about about business failures, focusing on startups and emerging companies. Jack of all spades. Master of none. Sometimes an enterprise — whether a startup or a multinational — can’t or shouldn’t try to do everything. Product design for example. If a company’s forte is ... say ... farm equipment, it ought think twice before getting into the baby...
12May
And Now … A Word from an Entrepreneur
Boston Harbor Angel members, Ziad Moukheiber and David Powsner, are the hosts of Failure – the Podcast, a podcast about about business failures, focusing on startups and emerging companies. A prior guest of the podcast likened markets to conversations. The entrepreneur introduces a product. The buying community accepts or rejects it. The entrepreneur tweaks and reintroduces the product. With luck, the buying community accepts it with more gusto. This back and forth, a conversation of sorts, continues until the entrepreneur and...
12May
Lions Clubs make a woman’s virtual world a reality
For the first time, Martin has seen a ray of hope for her eyesight. A friend told her about eSight. The eyewear device, which resembles a virtual reality headset, works in three steps. Read more >>
10May
Platelet BioGenesis Licenses Induced Pluripotent Stem Cell Technology from iPS Academia Japan
Platelet BioGenesis, a pioneer in the production of functional human platelets (PLTs+™) from stem cells, announced it has licensed patents related to induced pluripotent stem cells (“iPS cells”) from iPS Academia Japan’s patent portfolio. This non-exclusive agreement moves Platelet BioGenesis closer to its goal of producing functional human platelets at commercial scale. Read more >>
10May
Platelet BioGenesis Licenses Induced Pluripotent Stem Cell Technology from iPS Academia Japan
Platelet BioGenesis, a pioneer in the production of functional human platelets (PLTs+™) from stem cells, announced it has licensed patents related to induced pluripotent stem cells (“iPS cells”) from iPS Academia Japan’s patent portfolio. This non-exclusive agreement moves Platelet BioGenesis closer to its goal of producing functional human platelets at commercial scale. Read more >>
04May
Single-cell protein meal may support production, survival of rainbow trout
Diets supplemented with single-cell protein meal may support farmed trout production, feed efficiency and boost survival rates, says researcher. Read more >>
03May
KnipBio Touts results of newest trout feed study
Study found no significant difference in weight gain or feed conversion rates for trout. Read more >>
02May
Siamab Therapeutics Announces Publication of New Data on its ST1 Lead Program in the Journal Oncotarget
Siamab Therapeutics, Inc., a biopharmaceutical company developing novel glycan-targeted cancer therapeutics, today announced the publication of new preclinical data for its ST1 antibody drug conjugate (ADC) targeting the tumor-associated carbohydrate antigen (TACA) Sialyl-Tn (STn). Read more >>
01May